Browse Pharmaceutical industry topic

Securities subtopic

Articles 1-100 out of 100 article(s) Title Author Type Date Words Merck Announces Quarterly Dividends and New $3 Billion Share Repurchase Program. Nov 24, 2009 558 Ironwood Pharmaceuticals Files Registration Statement for Initial Public Offering. Nov 21, 2009 281 Medidata Solutions Files Registration Statement for Public Offering of Common Stock. Nov 20, 2009 428 Omnicare Declares Quarterly Cash Dividend. Nov 20, 2009 176 Salix Pharmaceuticals, Ltd. Announces Pricing of a Public Offering of Common Stock. Nov 18, 2009 520 HealthSport funding. Crowe, Deborah Brief article Nov 16, 2009 120 Fitch: Bristol-Myers Squibb's Ratings Unlikely to be Affected by Mead Johnson Spin-off. Nov 16, 2009 626 Fitch Revises Eli Lilly & Co.'s Outlook to Negative. Nov 13, 2009 668 Biovail Declares Quarterly Dividend. Nov 5, 2009 195 Fitch Downgrades Merck and Upgrades Schering-Plough to 'A+' Following Merger; Outlook Stable. Nov 4, 2009 1116 Columbia Laboratories Announces Registered Direct Common Stock Offering. Oct 23, 2009 900 Pfizer Declares a 16-Cent Fourth-Quarter 2009 Dividend. Oct 22, 2009 55 Hercules Technology Growth Capital Announces Three Portfolio Companies That Reached Multi-Million Dollar Milestones. Oct 20, 2009 1149 IMS Sets Fourth-Quarter 2009 Dividend. Oct 20, 2009 132 Fitch Downgrades Pfizer's IDR, Upgrades Wyeth's Ratings Following Completion of Aquisition. Oct 15, 2009 861 Battling swine flu: a small study revealed early clues for San Diego-based DNA vaccine company Inovio Biomedical last week. Chambers, Heather Brief article Oct 12, 2009 207 Targacept Announces Common Stock Offering. Oct 8, 2009 321 Targacept Announces Pricing of Common Stock Offering. Oct 8, 2009 339 Allos Therapeutics Announces Pricing of Public Offering of Common Stock. Oct 7, 2009 726 Allos Therapeutics Announces Proposed Public Offering of Common Stock. Oct 5, 2009 655 Dyax Announces Completion of Common Stock Offering. Oct 5, 2009 700 Dyax Announces Pricing of Public Offering of Common Stock. Sep 30, 2009 682 United States : Keryx expects $20 million from stock offering. Sep 29, 2009 159 Fitch Affirms Abbott Laboratories 'A+' IDR; Outlook Stable. Sep 28, 2009 550 Fitch: Credit Quality Stable for Global Pharma Sector With Increase of New Drug Approvals in 2Q'09. Sep 11, 2009 491 Hong Kong: Sinopharm Sees IPO Proceeds of About HK$7.42 Billion. Sep 11, 2009 509 Fitch Ratings Affirms McKesson's IDR at 'BBB+'; Outlook Stable. Sep 10, 2009 657 Bristol-Myers Squibb Announces Dividend. Sep 9, 2009 120 Fitch Affirms Bristol-Myers Squibb Co.'s IDR at 'A+'; Outlook Stable. Aug 27, 2009 609 United States : NovaBay Pharmaceuticals Announces the Closing of Its $2.45 Million Registered Direct Offering of Common Stock and Warrants. Aug 27, 2009 230 Startup works on getting injectable migraine treatment to market: flush with funding, Zogenix advances FDA-approved product. Chambers, Heather Aug 24, 2009 715 Mannatech Suspends Dividend. Aug 21, 2009 463 Fitch Rates Watson Pharmaceuticals' Proposed Sr. Unsecured Notes 'BBB-'; Affirms IDR at 'BBB-'. Aug 18, 2009 625 Adventrx lays out strategy for chemotherapy drug. Chambers, Heather Brief article Aug 10, 2009 176 Mylan launches generic headache drug based on Imitrex. Brief article Aug 10, 2009 140 Omnicare Declares Quarterly Cash Dividend. Aug 10, 2009 176 ARIAD Announces Completion of Public Offering of Common Stock and Full Exercise of Over-Allotment Option. Aug 7, 2009 432 Biovail Declares Quarterly Dividend. Aug 6, 2009 195 GW Pharmaceuticals plc - New Shares Issued Raising $11.2m (6.6m). Aug 6, 2009 1049 Inspire Announces Pricing of $100 Million Common Stock Offering. Aug 5, 2009 416 Inspire Announces Public Offering of Common Stock. Aug 4, 2009 422 ARIAD Prices Public Offering of Common Stock. Aug 4, 2009 349 ARIAD Announces Proposed Public Offering of Common Stock. Aug 3, 2009 306 Weight loss drug maker Orexigen Therapeutics has raised a hefty $70.9 million through the sale of 10 million shares of common stock. Chambers, Heather Brief article Aug 3, 2009 136 Merck Announces Fourth-Quarter 2009 Dividend. Jul 28, 2009 138 Fitch Expects Bristol-Myers Squibb's Ratings to Be Unaffected by Medarex Acquisition. Jul 23, 2009 546 Mid-Day Minute AcentsA[euro]A" July 22. Brief article Jul 22, 2009 283 China International Travel Service approved for $250 m IPO. Brief article Jul 21, 2009 230 IMS Sets Third-Quarter 2009 Dividend. Jul 20, 2009 132 Daily News Outlook - July 13. Jul 14, 2009 540 XenoPort Announces Pricing of Public Offering of Common Stock. Jul 8, 2009 316 XenoPort Announces Proposed Public Offering of Common Stock. Jul 7, 2009 679 Pfizer Declares a 16-Cent Third-Quarter 2009 Dividend. Jun 25, 2009 55 Fitch Affirms Johnson & Johnson's Ratings; Outlook Stable. Jun 24, 2009 512 ImmunoGen, Inc. Announces Completion of Public Offering of Common Stock. Jun 23, 2009 291 Fitch Rates Merck & Co.'s Debt Offering 'AA-'. Jun 22, 2009 493 ImmunoGen, Inc. Prices Public Offering of Common Stock. Jun 18, 2009 428 Fitch Affirms Watson Pharmaceuticals' IDR at 'BBB-'; Outlook Stable. Jun 18, 2009 699 ImmunoGen, Inc. Announces Proposed Public Offering of Common Stock. Jun 17, 2009 386 Bristol-Myers Squibb Announces Dividend. Jun 10, 2009 115 Fitch Global Pharmaceutical R&D Quarterly: New Medicines in 2009 On Track to Exceed 2008. Jun 8, 2009 368 Market summary. Brief article Jun 8, 2009 107 Merck Announces Third-Quarter 2009 Dividend. May 27, 2009 138 Fitch Rates Pfizer, Inc.'s Debt Offering 'AA'. May 26, 2009 329 Market summary. Brief article May 25, 2009 107 Omnicare Declares Quarterly Cash Dividend. May 22, 2009 176 30 SECOND GUIDE TO ... AAA. May 22, 2009 194 Mannatech Declares Dividend. May 20, 2009 476 Biovail Declares Quarterly Dividend, Announces Change in Dividend Policy. May 6, 2009 1058 Zacks Analyst Blog Highlights: General Motors Corp., Evergreen Solar, Inc., AMAG Pharmaceuticals, Inc., The Boeing Company and Micros Inc. May 4, 2009 853 Zacks Analyst Blog Highlights: DPL Inc, Hexcel Corp, Pozen Inc, LSI Corp and ExxonMobil Corp. May 1, 2009 1090 Fitch Affirms Royalty Pharma Finance Trust's IDR at 'BBB-'; Outlook Stable. Apr 24, 2009 481 Pfizer Hosts Annual Meeting Of Shareholders; Declares A 16-Cent Second-Quarter 2009 Dividend. Apr 23, 2009 532 IMS Sets Second-Quarter 2009 Dividend. Apr 21, 2009 132 Citigroup accused of selling securities as money market instruments. Brief article Apr 16, 2009 136 Zacks Analyst Blog Highlights: eBay Inc., ZymoGenetics, Inc., Bristol-Myers Squibb, Express Scripts, Inc. and WellPoint Inc. Apr 16, 2009 696 "Polar Tankers" Oral Argument Forthcoming And California Dividends Received Deduction Denied. Apr 15, 2009 782 Fitch Comments on WellPoint's Agreement to Sell PBM Subs. Apr 13, 2009 487 Anadys seeks partner to advance hepatitis C drug: biotech looks to tap billion-dollar market. Chambers, Heather Apr 13, 2009 433 Market summary. Brief article Apr 13, 2009 107 Fitch Global Pharmaceutical R&D Quarterly: 4th Qtr Regulatory Approvals Add to '08 Increases. Apr 9, 2009 283 Allos Therapeutics Announces Closing of Common Stock Offering. Apr 3, 2009 569 Allos Therapeutics Announces Pricing of Common Stock Offering. Mar 31, 2009 586 Fitch Revises Allergan's Rating Outlook to Stable; Affirms IDR at 'A-'. Mar 31, 2009 553 Julphar approves bonus shares, dividend payout. Mar 28, 2009 242 Fitch Rates Pfizer's $13.5B Senior Notes 'AA'. Mar 17, 2009 352 Fitch: Merck Merger to Offer Credit Benefits for Schering-Plough; SGP on Watch Positive. Mar 9, 2009 301 Fitch: Merck's Leverage to Increase on Schering-Plough Merger; Merck on Watch Negative. Mar 9, 2009 550 Fitch Rates Eli Lilly & Co.'s Senior Notes at 'A+'. Mar 3, 2009 388 Bristol-Myers Squibb Announces Dividend. Mar 3, 2009 115 Zacks Sell List Highlights: Ternium, City National Corp., Novartis and IDEX Corp. Feb 27, 2009 919 Biovail Declares Quarterly Dividend. Feb 26, 2009 229 Merck Announces Second-Quarter 2009 Dividend. Feb 24, 2009 138 Private placement for Cadence: Cadence Pharmaceuticals. Chambers, Heather Brief article Feb 23, 2009 157 Mannatech Declares Dividend. Feb 20, 2009 436 Fitch Affirms Amgen's IDR at 'A'; Outlook Stable. Feb 20, 2009 704 United States: Roche s $16 Billion Bond Sale Shows Demand for Debt. Feb 19, 2009 163 Vertex Pharmaceuticals Announces Pricing of Common Stock Offering. Feb 19, 2009 299 Vertex Pharmaceuticals Announces Proposed Public Offering of Common Stock. Feb 18, 2009 254 Precipitous Fall: Shares of La Jolla Pharmaceutical plummeted after the company said its experimental lupus drug Riquent failed to meet its goals in a late-stage study. Chambers, Heather Brief article Feb 16, 2009 127